查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1264006

乳癌診察市場:規模，全球市場的預測(2023年～2028年)，產業趨勢，成長，佔有率，預測，通貨膨脹的影響，企業的機會分析

Breast Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
出版日期: | 出版商: Renub Research | 英文 450 Pages | 商品交期: 最快1-2個工作天內

價格

全球乳癌診察的市場規模在2022年估算為16億4,000萬美金，2028年將達到21億2,000萬美元。2022年～2028年預計將以年複合成長率5.26％的速度成長。隨著全球乳癌罹患率的上升，乳癌診察服務的需求也提高。

本報告提供全球乳癌診察市場相關調查，提供市場概要，以及各類型乳癌體檢趨勢，各國的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 促進因素
  • 課題

第5章 波特的五力分析

第6章 全球乳癌診察市場

第7章 全球乳癌診察人口，各類型

  • 乳房X光攝影診察人口
  • MRI及超音波篩檢人口

第8章 全球乳癌診察市場，各類型

  • 乳房X光攝影診察市場
  • 核磁共振影像(MRI)篩檢市場
  • 超音波篩檢市場

第9章 人口佔有率-全球乳癌診察

  • 乳癌診察
  • 乳房X光攝影篩檢
  • MRI及超音波篩檢

第10章 市場佔有率-世界乳癌診察

  • 乳癌診察
  • 乳房X光攝影篩檢
  • MRI篩檢
  • 超音波篩檢

第11章 英國-乳癌診察的人口與市場

第12章 法國-乳癌診察人口與市場

第13章 德國-乳癌診察人口與市場

第14章 義大利-乳癌診察人口與市場

第15章 西班牙-乳癌診察人口與市場

第16章 瑞士-乳癌診察人口與市場

第17章 挪威-乳癌診察人口與市場

第18章 荷蘭-乳癌診察人口與市場

第19章 美國-乳癌診察人口與市場

第20章 加拿大-乳癌診察人口與市場

第21章 日本-乳癌診察人口與市場

第22章 韓國-乳癌診察人口與市場

第23章 新加坡-乳癌診察人口與市場

第24章 馬來西亞-乳癌診察人口與市場

第25章 印度-乳癌診察人口與市場

第26章 中國-乳癌診察人口與市場

第27章 泰國-乳癌診察人口與市場

第28章 巴西-乳癌診察人口與市場

第29章 澳洲-乳癌診察人口與市場

第30章 紐西蘭-乳癌診察人口與市場

第31章 南非-乳癌診察人口與市場

第32章 阿拉伯聯合大公國-乳癌診察人口與市場

第33章 沙烏地阿拉伯-乳癌診察人口與市場

第34章 其他地區-乳癌診察人口與市場

第35章 企業分析

  • AstraZeneca
  • Novartis
  • Sanofi
  • Pfizer
  • Bayer AG
  • GlaxoSmithKline plc

Global Breast Cancer Screening Market will reach US$ 2.12 Billion in 2028, according to Renub Research. Breast cancer screening can detect cancer early, even before any symptoms are present. Early detection is vital because it allows for more effective treatment options and increases the chances of a successful outcome. When breast cancer is detected early, more treatment options are available, including less invasive treatments and the possibility of breast-conserving surgery. In addition, breast cancer screening is cost-effective, as the cost of screening is significantly lower than that of treating advanced breast cancer.

Breastcancer.org's 2022 update projects that in the United States, 287,850 individuals received a diagnosis of invasive breast cancer, and an additional 51,400 individuals were diagnosed with non-invasive (in situ) breast cancer

Breast cancer screening markets shall experience a CAGR of 5.26% from 2022 to 2028

The demand for breast cancer screening services has been increasing due to the rising incidence of breast cancer worldwide. According to the World Health Organization (WHO), breast cancer is the most prevalent type of cancer globally, with over 2.3 million new cases. A growing awareness has fuelled this rise in demand for screening services among women about the importance of breast cancer screening. As a result, women are encouraged to undergo screening through various campaigns, educational programs, and advocacy groups. Additionally, the aging of the population has also played a role in the increased demand for breast cancer screening services, as frequent diagnosis of breast cancer is common in older women.

Governments have implemented screening programs and policies to increase access to breast cancer screening, particularly for underserved populations. In addition, technological advancements have led to the development of more accurate and less invasive screening methods, such as digital mammography, breast ultrasound, and magnetic resonance imaging (MRI), which have improved the detection of breast cancer. For instance, in March 2022, LifeCell launched Breast Screen Panel, a comprehensive genetic screening test assessing women's risk of breast cancer. Hence, the market value for the global breast cancer screening market was US$ 1.64 Billion in 2022.

Increased Awareness, Technological Advancements, and Government Initiatives have led to the growing demand for Breast Cancer Screening Services in India

Countries present in the breast cancer screening market are the United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, United Arab Emirates, Saudi Arabia, and Rest of World. Increasing disposable income in India has allowed more individuals to afford breast cancer screening services, awareness campaigns, and government initiatives, raising women's awareness about the importance of breast cancer screening and improving access to screening services, particularly for underserved populations. In addition, government initiatives such as the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) and the National Health Mission (NHM) have improved access to breast cancer screening in India.

In China, improved access to healthcare services, including breast cancer screening, can be attributed to the country's recent increase in healthcare spending. Additionally, the Chinese government has launched various initiatives to improve access to breast cancer screening, focusing on underserved populations. An example of such an initiative is the National Breast Cancer Screening Program, which offers free breast cancer screening to women living in rural areas.

High Incidence of Breast Cancer in the United States has increased the emphasis on Breast Cancer Screening

Based on the Mammography breast cancer screening, there are 24 divisions - United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, United Arab Emirates, Saudi Arabia, and Rest of World. Health insurance plans cover mammography, making it more accessible and affordable. In addition, advanced mammography technology has improved the accuracy of screening. The government has implemented policies to increase access to mammography, including initiatives to achieve "zero fatalities from breast cancer" by 2030, as announced by the National Breast Cancer Foundation, with USD 12.4 Million in funding for 20 research initiatives.

Private Healthcare Sector in Brazil Embraces Advanced Breast Cancer Screening Technologies Amid Growing Awareness among Women.

The countries where MRI breast cancer screening is prevalent are the United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and Rest of World. The private healthcare sector in Brazil has been investing in advanced breast cancer screening technologies, including MRI, to provide more accurate and effective screening services. Furthermore, there has been a growing awareness among women in Brazil about the importance of breast cancer screening, driven by campaigns, educational programs, and advocacy groups.

China shall have the Highest Share in the Ultrasound Screening Industry

United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and Rest of World, is the different countries in the ultrasound breast cancer screening market. Ultrasound screening is safe and effective, particularly for younger women and women with dense breast tissue. The Chinese government has implemented initiatives to increase access to breast cancer screening, including promoting ultrasound screening as a primary screening method.

Additionally, the development and adoption of advanced ultrasound technology have improved the accuracy and effectiveness of ultrasound screening in detecting breast cancer.

There has been a growing emphasis on using ultrasound screening as a complement to mammography, particularly for women with dense breast tissue leading to increased adoption and utilization of ultrasound screening in the United States. Moreover, the United States has been a leader in developing and adopting advanced ultrasound technology, including 3D and 4D ultrasound, improving the accuracy and effectiveness of ultrasound screening in detecting breast cancer.

Key Players Analysis

AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc are significant companies competing in Breast Cancer Screening Market.

In June 2022, Walmart signed a general merchandise supplier agreement with Biomerica, Inc to sell the Aware Breast Self-Exam device in its retail system.

Renub Research report titled "Global Breast Cancer Screening Market Global Forecast by breast cancer screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW), Mammography screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW), MRI Screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW) Ultrasound Screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW), Company Analysis (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc)" provides a detailed analysis of Global breast cancer screening Market.

Breast Cancer Screening- Market breakup of 24 Countries:

1. United Kingdom

2. France

3. Germany

4. Italy

5. Spain

6. Switzerland

7. Norway

8. Netherlands

9. New Zealand

10. Australia

11. United States

12. Canada

13. Japan

14. Korea

15. Singapore

16. India

17. Thailand

18. Malaysia

19. China

20. Brazil

21. South Africa

22. United Arab Emirates

23. Saudi Arabia

24. Rest of World

Mammography Screening - Market breakup from 24 Viewpoints:

1. United Kingdom

2. France

3. Germany

4. Italy

5. Spain

6. Switzerland

7. Norway

8. Netherlands

9. New Zealand

10. Australia

11. United States

12. Canada

13. Japan

14. Korea

15. Singapore

16. India

17. Thailand

18. Malaysia

19. China

20. Brazil

21. South Africa

22. United Arab Emirates

23. Saudi Arabia

24. Rest of World

MRI Screening- Market breakup from 24 Viewpoints:

1. United Kingdom

2. France

3. Germany

4. Italy

5. Spain

6. Switzerland

7. Norway

8. Netherlands

9. New Zealand

10. Australia

11. United States

12. Canada

13. Japan

14. Korea

15. Singapore

16. India

17. Thailand

18. Malaysia

19. China

20. Brazil

21. South Africa

22. United Arab Emirates

23. Saudi Arabia

24. Rest of World

Ultrasound Screening- Market breakup from 24 Viewpoints:

1. United Kingdom

2. France

3. Germany

4. Italy

5. Spain

6. Switzerland

7. Norway

8. Netherlands

9. New Zealand

10. Australia

11. United States

12. Canada

13. Japan

14. Korea

15. Singapore

16. India

17. Thailand

18. Malaysia

19. China

20. Brazil

21. South Africa

22. United Arab Emirates

23. Saudi Arabia

24. Rest of World

Company has been covered from 3 Viewpoints:

  • Overview
  • Recent Development
  • Revenue

Company Analysis:

1. AstraZeneca

2. Novartis

3. Sanofi

4. Pfizer

5. Bayer AG

6. GlaxoSmithKline plc

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Porter's Five Forces

  • 5.1 Bargaining Power of Buyers
  • 5.2 Bargaining Power of Suppliers
  • 5.3 Degree of Competition
  • 5.4 Threat of New Entrants
  • 5.5 Threat of Substitutes

6. Global Breast Cancer Screening Market

  • 6.1 Market
  • 6.2 Population (Thousand)

7. By Types - Global Breast Cancer Screening Population

  • 7.1 Mammography Screening Population
  • 7.2 MRI & Ultrasound Screening Population

8. By Types - Global Breast Cancer Screening Market

  • 8.1 Mammography Screening Market
  • 8.2 Magnetic Resonance Imaging (MRI) Screening Market
  • 8.3 Ultrasound Screening Market

9. Population Share - Global Breast Cancer Screening

  • 9.1 Breast Cancer Screening
  • 9.2 Mammography Screening
  • 9.3 MRI & Ultrasound Screening

10. Market Share - Global Breast Cancer Screening

  • 10.1 Breast Cancer Screening
  • 10.2 Mammography Screening
  • 10.3 MRI Screening
  • 10.4 Ultrasound Screening

11. United Kingdom - Breast Cancer Screening Population & Market

  • 11.1 United Kingdom Breast Cancer Screening Population & Forecast
    • 11.1.1 Mammography Screening Population
    • 11.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 11.2 United Kingdom Breast Cancer Screening Market & Forecast
    • 11.2.1 Mammography Screening Market
    • 11.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 11.2.3 Ultrasound Screening Market

12. France - Breast Cancer Screening Population & Market

  • 12.1 France Breast Cancer Screening Population & Forecast
    • 12.1.1 Mammography Screening Population
    • 12.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 12.2 France Breast Cancer Screening Market & Forecast
    • 12.2.1 Breast Cancer Mammography Screening Market
    • 12.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 12.2.3 Ultrasound Screening Market

13. Germany - Breast Cancer Screening Population & Market

  • 13.1 Germany Breast Cancer Screening Population & Forecast
    • 13.1.1 Mammography Screening Population
    • 13.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 13.2 Germany Breast Cancer Screening Market & Forecast
    • 13.2.1 Breast Cancer Mammography Screening Market
    • 13.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 13.2.3 Ultrasound Screening Market

14. Italy - Breast Cancer Screening Population & Market

  • 14.1 Italy Breast Cancer Screening Population & Forecast
    • 14.1.1 Mammography Screening Population
    • 14.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 14.2 Italy Breast Cancer Screening Market & Forecast
    • 14.2.1 Mammography Screening Market
    • 14.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 14.2.3 Ultrasound Screening Market

15. Spain - Breast Cancer Screening Population & Market

  • 15.1 Spain Breast Cancer Screening Population & Forecast
    • 15.1.1 Mammography Screening Population
    • 15.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 15.2 Spain Breast Cancer Screening Market & Forecast
    • 15.2.1 Mammography Screening Market
    • 15.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 15.2.3 Ultrasound Screening Market

16. Switzerland - Breast Cancer Screening Population & Market

  • 16.1 Switzerland Breast Cancer Screening Population & Forecast
    • 16.1.1 Mammography Screening Population
    • 16.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 16.2 Switzerland Breast Cancer Screening Market & Forecast
    • 16.2.1 Mammography Screening Market
    • 16.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 16.2.3 Ultrasound Screening Market

17. Norway - Breast Cancer Screening Population & Market

  • 17.1 Norway Breast Cancer Screening Population & Forecast
    • 17.1.1 Mammography Screening Population
    • 17.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 17.2 Norway Breast Cancer Screening Market & Forecast
    • 17.2.1 Mammography Screening Market
    • 17.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 17.2.3 Ultrasound Screening Market

18. Netherlands - Breast Cancer Screening Population & Market

  • 18.1 Netherlands Breast Cancer Screening Population & Forecast
    • 18.1.1 Mammography Screening Population
    • 18.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 18.2 Netherlands Breast Cancer Screening Market & Forecast
    • 18.2.1 Mammography Screening Market
    • 18.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 18.2.3 Ultrasound Screening Market

19. United States - Breast Cancer Screening Population & Market

  • 19.1 United States Breast Cancer Screening Population & Forecast
    • 19.1.1 Mammography Screening Population
    • 19.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 19.2 United States Breast Cancer Screening Market & Forecast
    • 19.2.1 Mammography Screening Market
    • 19.2.2 Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market
    • 19.2.3 Ultrasound Screening Market

20. Canada - Breast Cancer Screening Population & Market

  • 20.1 Canada Breast Cancer Screening Population & Forecast
    • 20.1.1 Mammography Screening Population
    • 20.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 20.2 Canada Breast Cancer Screening Market & Forecast
    • 20.2.1 Mammography Screening Market
    • 20.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 20.2.3 Ultrasound Screening Market

21. Japan - Breast Cancer Screening Population & Market

  • 21.1 Japan Breast Cancer Screening Population & Forecast
    • 21.1.1 Mammography Screening Population
    • 21.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 21.2 Japan Breast Cancer Screening Market & Forecast
    • 21.2.1 Mammography Screening Market
    • 21.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 21.2.3 Ultrasound Screening Market

22. Korea - Breast Cancer Screening Population & Market

  • 22.1 Korea Breast Cancer Screening Population & Forecast
    • 22.1.1 Mammography Screening Population
    • 22.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 22.2 Korea Breast Cancer Screening Market & Forecast
    • 22.2.1 Mammography Screening Market
    • 22.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 22.2.3 Ultrasound Screening Market

23. Singapore - Breast Cancer Screening Population & Market

  • 23.1 Singapore Breast Cancer Screening Population & Forecast
    • 23.1.1 Mammography Screening Population
    • 23.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 23.2 Singapore Breast Cancer Screening Market & Forecast
    • 23.2.1 Mammography Screening Market
    • 23.2.2 Resonance Imaging (MRI) Screening Market
    • 23.2.3 Ultrasound Screening Market

24. Malaysia - Breast Cancer Screening Population & Market

  • 24.1 Malaysia Breast Cancer Screening Population & Forecast
    • 24.1.1 Mammography Screening Population
    • 24.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 24.2 Malaysia Breast Cancer Screening Market & Forecast
    • 24.2.1 Mammography Screening Market
    • 24.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 24.2.3 Ultrasound Screening Market

25. India - Breast Cancer Screening Population & Market

  • 25.1 India Breast Cancer Screening Population & Forecast
    • 25.1.1 Mammography Screening Population
    • 25.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 25.2 India Breast Cancer Screening Market & Forecast
    • 25.2.1 Mammography Screening Market
    • 25.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 25.2.3 Ultrasound Screening Market

26. China - Breast Cancer Screening Population & Market

  • 26.1 China Breast Cancer Screening Population & Forecast
    • 26.1.1 Mammography Screening Population
    • 26.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 26.2 China Breast Cancer Screening Market & Forecast
    • 26.2.1 Mammography Screening Market
    • 26.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 26.2.3 Ultrasound Screening Market

27. Thailand - Breast Cancer Screening Population & Market

  • 27.1 Thailand Breast Cancer Screening Population & Forecast
    • 27.1.1 Mammography Screening Population
    • 27.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 27.2 Thailand Breast Cancer Screening Market & Forecast
    • 27.2.1 Mammography Screening Market
    • 27.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 27.2.3 Ultrasound Screening Market

28. Brazil - Breast Cancer Screening Population & Market

  • 28.1 Brazil Breast Cancer Screening Population & Forecast
    • 28.1.1 Mammography Screening Population
    • 28.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 28.2 Brazil Breast Cancer Screening Market & Forecast
    • 28.2.1 Mammography Screening Market
    • 28.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 28.2.3 Ultrasound Screening Market

29. Australia - Breast Cancer Screening Population & Market

  • 29.1 Australia Breast Cancer Screening Population & Forecast
    • 29.1.1 Mammography Screening Population
    • 29.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 29.2 Australia Breast Cancer Screening Market & Forecast
    • 29.2.1 Mammography Screening Market
    • 29.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 29.2.3 Ultrasound Screening Market

30. New Zealand - Breast Cancer Screening Population & Market

  • 30.1 New Zealand Breast Cancer Screening Population & Forecast
    • 30.1.1 Mammography Screening Population
    • 30.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 30.2 New Zealand Breast Cancer Screening Market & Forecast
    • 30.2.1 Mammography Screening Market
    • 30.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 30.2.3 Ultrasound Screening Market

31. South Africa - Breast Cancer Screening Population & Market

  • 31.1 South Africa Breast Cancer Screening Population & Forecast
    • 31.1.1 Mammography Screening Population
    • 31.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 31.2 South Africa Breast Cancer Screening Market & Forecast
    • 31.2.1 Mammography Screening Market
    • 31.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 31.2.3 Ultrasound Screening Market

32. United Arab Emirates - Breast Cancer Screening Population & Market

  • 32.1 United Arab Emirates Breast Cancer Screening Population & Forecast
    • 32.1.1 Mammography Screening Population
    • 32.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 32.2 United Arab Emirates Breast Cancer Screening Market & Forecast
    • 32.2.1 Mammography Screening Market
    • 32.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 32.2.3 Ultrasound Screening Market

33. Saudi Arabia - Breast Cancer Screening Population & Market

  • 33.1 Saudi Arabia Breast Cancer Screening Population & Forecast
    • 33.1.1 Mammography Screening Population
    • 33.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 33.2 Saudi Arabia Breast Cancer Screening Market & Forecast
    • 33.2.1 Mammography Screening Market
    • 33.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 33.2.3 Ultrasound Screening Market

34. ROW - Breast Cancer Screening Population & Market

  • 34.1 ROW Breast Cancer Screening Population & Forecast
    • 34.1.1 Mammography Screening Population
    • 34.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 34.2 ROW Breast Cancer Screening Market & Forecast
    • 34.2.1 Mammography Screening Market
    • 34.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 34.2.3 Ultrasound Screening Market

35. Company Analysis

  • 35.1 AstraZeneca
    • 35.1.1 Overviews
    • 35.1.2 Resent Development
    • 35.1.3 Revenue
  • 35.2 Novartis
    • 35.2.1 Overviews
    • 35.2.2 Resent Development
    • 35.2.3 Revenue
  • 35.3 Sanofi
    • 35.3.1 Overviews
    • 35.3.2 Resent Development
    • 35.3.3 Revenue
  • 35.4 Pfizer
    • 35.4.1 Overviews
    • 35.4.2 Resent Development
    • 35.4.3 Revenue
  • 35.5 Bayer AG
    • 35.5.1 Overviews
    • 35.5.2 Resent Development
    • 35.5.3 Revenue
  • 35.6 GlaxoSmithKline plc
    • 35.6.1 Overviews
    • 35.6.2 Resent Development
    • 35.6.3 Revenue

List of Figures

  • Figure-01: Global - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-02: Global - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-03: Global - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-04: Global - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-05: Global - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-06: Global - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-07: Global - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-08: Global - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-09: Global - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-10: Global - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-11: United Kingdom - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-12: United Kingdom - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-13: United Kingdom - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-14: United Kingdom - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-15: United Kingdom - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-16: United Kingdom - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-17: United Kingdom - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-18: United Kingdom - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-19: United Kingdom - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-20: United Kingdom - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-21: France - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-22: France - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-23: France - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-24: France - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-25: France - Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-26: France - Forecast for Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-27: France - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-28: France - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-29: France - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-30: France - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-31: Germany - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-32: Germany - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-33: Germany - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-34: Germany - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-35: Germany - Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-36: Germany - Forecast for Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-37: Germany - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-38: Germany - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-39: Germany - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-40: Germany - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-41: Italy - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-42: Italy - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-43: Italy - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-44: Italy - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-45: Italy - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-46: Italy - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-47: Italy - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-48: Italy - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-49: Italy - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-50: Italy - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-51: Spain - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-52: Spain - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-53: Spain - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-54: Spain - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-55: Spain - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-56: Spain - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-57: Spain - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-58: Spain - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-59: Spain - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-60: Spain - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-61: Switzerland - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-62: Switzerland - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-63: Switzerland - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-64: Switzerland - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-65: Switzerland - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-66: Switzerland - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-67: Switzerland - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-68: Switzerland - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-69: Switzerland - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-70: Switzerland - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-71: Norway - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-72: Norway - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-73: Norway - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-74: Norway - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-75: Norway - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-76: Norway - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-77: Norway - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-78: Norway - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-79: Norway - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-80: Norway - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-81: Netherlands - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-82: Netherlands - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-83: Netherlands - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-84: Netherlands - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-85: Netherlands - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-86: Netherlands - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-87: Netherlands - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-88: Netherlands - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-89: Netherlands - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-90: Netherlands - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-91: United States - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-92: United States - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-93: United States - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-94: United States - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-95: United States - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-96: United States - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-97: United States - Breast Cancer Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-98: United States - Forecast for Breast Cancer Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-99: United States - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-100: United States - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-101: Canada - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-102: Canada - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-103: Canada - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-104: Canada - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-105: Canada - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-106: Canada - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-107: Canada - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-108: Canada - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-109: Canada - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-110: Canada - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-111: Japan - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-112: Japan - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-113: Japan - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-114: Japan - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-115: Japan - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-116: Japan - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-117: Japan - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-118: Japan - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-119: Japan - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-120: Japan - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-121: Korea - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-122: Korea - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-123: Korea - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-124: Korea - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-125: Korea - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-126: Korea - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-127: Korea - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-128: Korea - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-129: Korea - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-130: Korea - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-131: Singapore - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-132: Singapore - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-133: Singapore - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-134: Singapore - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-135: Singapore - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-136: Singapore - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-137: Singapore - Breast Cancer Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-138: Singapore - Forecast for Breast Cancer Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-139: Singapore - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-140: Singapore - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-141: Malaysia - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-142: Malaysia - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-143: Malaysia - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-144: Malaysia - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-145: Malaysia - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-146: Malaysia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-147: Malaysia - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-148: Malaysia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-149: Malaysia - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-150: Malaysia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-151: India - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-152: India - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-153: India - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-154: India - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-155: India - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-156: India - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-157: India - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-158: India - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-159: India - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-160: India - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-161: China - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-162: China - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-163: China - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-164: China - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-165: China - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-166: China - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-167: China - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-168: China - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-169: China - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-170: China - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-171: Thailand - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-172: Thailand - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-173: Thailand - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-174: Thailand - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-175: Thailand - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-176: Thailand - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-177: Thailand - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-178: Thailand - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-179: Thailand - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-180: Thailand - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-181: Brazil - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-182: Brazil - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-183: Brazil - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-184: Brazil - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-185: Brazil - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-186: Brazil - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-187: Brazil - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-188: Brazil - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-189: Brazil - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-190: Brazil - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-191: Australia - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-192: Australia - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-193: Australia - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-194: Australia - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-195: Australia - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-196: Australia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-197: Australia - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-198: Australia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-199: Australia - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-200: Australia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-201: New Zealand - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-202: New Zealand - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-203: New Zealand - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-204: New Zealand - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-205: New Zealand - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-206: New Zealand - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-207: New Zealand - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-208: New Zealand - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-209: New Zealand - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-210: New Zealand - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-211: South Africa - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-212: South Africa - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-213: South Africa - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-214: South Africa - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-215: South Africa - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-216: South Africa - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-217: South Africa - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-218: South Africa - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-219: South Africa - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-220: South Africa - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-221: United Arab Emirates - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-222: United Arab Emirates - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-223: United Arab Emirates - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-224: United Arab Emirates - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-225: United Arab Emirates - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-226: United Arab Emirates - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-227: United Arab Emirates - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-228: United Arab Emirates - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-229: United Arab Emirates - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-230: United Arab Emirates - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-231: Saudi Arabia - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-232: Saudi Arabia - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-233: Saudi Arabia - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-234: Saudi Arabia - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-235: Saudi Arabia - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-236: Saudi Arabia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-237: Saudi Arabia - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-238: Saudi Arabia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-239: Saudi Arabia - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-240: Saudi Arabia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-241: Rest of World - Breast Cancer Mammography Screening Population Volume (Thousand), 2018 - 2022
  • Figure-242: Rest of World - Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 - 2028
  • Figure-243: Rest of World - Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 - 2022
  • Figure-244: Rest of World - Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 - 2028
  • Figure-245: Rest of World - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
  • Figure-246: Rest of World - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
  • Figure-247: Rest of World - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
  • Figure-248: Rest of World - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
  • Figure-249: Rest of World - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
  • Figure-250: Rest of World - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
  • Figure-251: AstraZeneca - Global Revenue (Billion US$), 2018 - 2022
  • Figure-252: AstraZeneca - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-253: Novartis - Global Revenue (Billion US$), 2018 - 2022
  • Figure-254: Novartis - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-255: Sanofi - Global Revenue (Billion US$), 2018 - 2022
  • Figure-256: Sanofi - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-257: Pfizer - Global Revenue (Billion US$), 2018 - 2022
  • Figure-258: Pfizer - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-259: Bayer AG - Global Revenue (Billion US$), 2018 - 2022
  • Figure-260: Bayer AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-261: GlaxoSmithKline plc - Global Revenue (Billion US$), 2018 - 2022
  • Figure-262: GlaxoSmithKline plc - Forecast for Global Revenue (Billion US$), 2023 - 2028

List of Tables

  • Table-01: Global - Breast Cancer Screening Population Share by Countries (Percent), 2018 - 2022
  • Table-02: Global - Forecast for Breast Cancer Screening Population Share by Countries (Percent), 2023 - 2028
  • Table-03: Global - Mammography Screening Population Share by Countries (Percent), 2018 - 2022
  • Table-04: Global - Forecast for Mammography Screening Population Share by Countries (Percent), 2023 - 2028
  • Table-05: Global - MRI and Ultrasound Screening Population Share by Countries (Percent), 2018 - 2022
  • Table-06: Global - Forecast for MRI and Ultrasound Screening Population Share by Countries (Percent), 2023 - 2028
  • Table-07: Global - Breast Cancer Screening Market Share by Countries (Percent), 2018 - 2022
  • Table-08: Global - Forecast for Breast Cancer Screening Market Share by Countries (Percent), 2023 - 2028
  • Table-09: Global - Mammography Screening Market Share by Countries (Percent), 2018 - 2022
  • Table-10: Global - Forecast for Mammography Screening Market Share by Countries (Percent), 2023 - 2028
  • Table-11: Global - MRI Screening Market Share by Countries (Percent), 2018 - 2022
  • Table-12: Global - Forecast for MRI Screening Market Share by Countries (Percent), 2023 - 2028
  • Table-13: Global - Ultrasound Screening Market Share by Countries (Percent), 2018 - 2022
  • Table-14: Global - Forecast for Ultrasound Screening Market Share by Countries (Percent), 2023 - 2028